1. Home
  2. SHEL vs AZN Comparison

SHEL vs AZN Comparison

Compare SHEL & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shell PLC (each representing two (2))

SHEL

Shell PLC (each representing two (2))

HOLD

Current Price

$73.73

Market Cap

208.6B

Sector

Energy

ML Signal

HOLD

Logo AstraZeneca PLC

AZN

AstraZeneca PLC

HOLD

Current Price

$93.76

Market Cap

283.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHEL
AZN
Founded
1907
1992
Country
United Kingdom
United Kingdom
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
208.6B
283.9B
IPO Year
N/A
1993

Fundamental Metrics

Financial Performance
Metric
SHEL
AZN
Price
$73.73
$93.76
Analyst Decision
Buy
Strong Buy
Analyst Count
8
2
Target Price
$81.19
N/A
AVG Volume (30 Days)
4.9M
5.2M
Earning Date
02-05-2026
02-10-2026
Dividend Yield
3.85%
1.59%
EPS Growth
N/A
45.02
EPS
2.42
6.02
Revenue
$269,075,000,000.00
$58,127,000,000.00
Revenue This Year
N/A
$11.40
Revenue Next Year
N/A
$6.06
P/E Ratio
$30.74
$16.01
Revenue Growth
N/A
13.52
52 Week Low
$58.55
$61.24
52 Week High
$77.47
$96.51

Technical Indicators

Market Signals
Indicator
SHEL
AZN
Relative Strength Index (RSI) 53.34 54.37
Support Level $68.63 $92.78
Resistance Level $74.89 $96.43
Average True Range (ATR) 1.15 1.52
MACD 0.14 0.05
Stochastic Oscillator 72.94 60.24

Price Performance

Historical Comparison
SHEL
AZN

About SHEL Shell PLC (each representing two (2))

Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2024, it produced 1.5 million barrels of liquids and 7.7 billion cubic feet of natural gas per day. At year-end 2024, reserves stood at 9.6 billion barrels of oil equivalent, 48% of which consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with a capacity of 1.6 mmb/d located in the Americas, Asia, and Europe, and sells about 12 million tons per year of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.

About AZN AstraZeneca PLC

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.

Share on Social Networks: